International Business News: NEW DELHI: Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regu.
According to the latest Enforcement Report issued by the USFDA, a New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. - Newsx
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023.